Stay updated on Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.0.2. The older Revision: v3.0.1 tag and the Back to Top element have been removed, and the MedlinePlus Genetics topic 'Melanoma' has been deleted.
    Difference
    0.2%
    Check dated 2025-09-14T18:52:58.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated to include information on Melanoma under MedlinePlus Genetics, and the version has been revised from v3.0.0 to v3.0.1.
    Difference
    0.2%
    Check dated 2025-09-07T13:53:00.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility and location information, as well as recent publications related to pembrolizumab and melanoma, while removing outdated location details and certain related topics.
    Difference
    4%
    Check dated 2025-08-31T11:37:34.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.10 to v2.16.12, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-08-17T01:37:51.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.6%
    Check dated 2025-08-02T18:28:05.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.
    Difference
    0.1%
    Check dated 2025-07-26T14:43:34.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.